biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > This Will Be Interesting

<< Previous

Bullboard Posts

Next >>

Comment by Georgeparroson Dec 13, 2022 1:05pm

106 Views

Post# 35168870

RE:RE:This Will Be Interesting

I do think Lind, Thalenburg, Rathjen and Saltarelli are happier in this deal. Screw the others.

Could someone step up to the plate if it doesnt go through.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec